We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTR icon
3876
Avantor
AVTR
$9.37B
$19K ﹤0.01%
842
-31,490
-97% -$655K
AZUL
3877
DELISTED
Azul
AZUL
$19K ﹤0.01%
+1,456
New +$18.7K
CIGI icon
3878
Colliers International
CIGI
$5.41B
$19K ﹤0.01%
285
-1,850
-87% -$112K
CLSD
3879
DELISTED
Clearside Biomedical
CLSD
$19K ﹤0.01%
831
+756
+1,008% +$19.5K
FPH icon
3880
Five Point Holdings
FPH
$372M
$19K ﹤0.01%
+4,550
New +$22.1K
ICLR icon
3881
Icon
ICLR
$12.9B
$19K ﹤0.01%
+97
New +$17.8K
IIM icon
3882
Invesco Value Municipal Income Trust
IIM
$603M
$19K ﹤0.01%
+1,264
New +$18.9K
LEU icon
3883
Centrus Energy
LEU
$3.83B
$19K ﹤0.01%
2,264
+2,089
+1,194% +$24.7K
ST icon
3884
Sensata Technologies
ST
$6.61B
$19K ﹤0.01%
+429
New +$17.4K
VERX icon
3885
Vertex
VERX
$2.15B
$19K ﹤0.01%
+839
New +$20.4K
EVA
3886
DELISTED
Enviva Inc.
EVA
$19K ﹤0.01%
475
-1,992
-81% -$78.3K
BPMP
3887
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$19K ﹤0.01%
1,867
-6,323
-77% -$69.3K
SHSP
3888
DELISTED
SharpSpring, Inc.
SHSP
$19K ﹤0.01%
1,757
-1,273
-42% -$12.2K
SWI
3889
DELISTED
SolarWinds Corporation Common Stock
SWI
$19K ﹤0.01%
904
+826
+1,059% +$16.8K
LVGO
3890
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$19K ﹤0.01%
138
-7,073
-98% -$862K
TRQ
3891
DELISTED
Turquoise Hill Resources Ltd
TRQ
$19K ﹤0.01%
+2,287
New +$20.4K
HHR
3892
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$19K ﹤0.01%
+790
New +$16.8K
ANIK icon
3893
Anika Therapeutics
ANIK
$283M
$18K ﹤0.01%
516
-1,524
-75% -$55K
ARCO icon
3894
Arcos Dorados Holdings
ARCO
$1.71B
$18K ﹤0.01%
4,468
+2,519
+129% +$11.3K
CUE icon
3895
Cue Biopharma
CUE
$131M
$18K ﹤0.01%
39
-216
-85% -$124K
DAC icon
3896
Danaos Corp
DAC
$2.56B
$18K ﹤0.01%
2,454
+1,359
+124% +$6.48K
EWH icon
3897
iShares MSCI Hong Kong ETF
EWH
$1.21B
$18K ﹤0.01%
800
-7,085
-90% -$156K
ILCV icon
3898
iShares Morningstar Value ETF
ILCV
$1.36B
$18K ﹤0.01%
362
-16,196
-98% -$810K
NNVC icon
3899
NanoViricides
NNVC
$34.7M
$18K ﹤0.01%
+4,629
New +$25.4K
PUK icon
3900
Prudential
PUK
$34.5B
$18K ﹤0.01%
+634
New +$19K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.